Trademark Overview
On Thursday, July 10, 2025, a trademark application was filed for TRANSGENE with the United States Patent and Trademark Office. The USPTO has given the TRANSGENE trademark a serial number of 79429882. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Friday, December 19, 2025. This trademark is owned by TRANSGENE. The TRANSGENE trademark is filed in the Pharmaceutical Products category with the following description:
Medicines; anti-cancer medicines; cancer treatment compounds; pharmaceutical preparations and substances for cancer treatment and/or prevention; immunotherapeutic products and agents in oncology; immunotherapeutic products and agents for bacterial infections; customized immunotherapy products; products to stimulate and modulate the immune system; oncolytic viruses; medicinal preparations and pharmaceutical preparations for the treatment of infectious or genetic diseases; pharmaceutical preparations for use in chemotherapy; chemotherapeutic agents; Pharmaceutical substances and preparations used in oncology; vaccines; cancer vaccines; therapeutic vaccines in oncology or genetics; viral vaccines; tumor antigens; viral antigens; vaccine adjuvant; Chemicals and biochemicals for medical and clinical use; agents and reagents for medical or clinical use; chemical or biochemical test kits; reagents for medical and clinical use comprising preparations, agents and reagents; Pharmaceutical produc...
